Damian Green | BiotechTV

top of page

Miami Oncology Summit: Damian Green, Chief of Sylvester's Division of Transplantation and Cellular Therapy, discusses the latest in CAR-T and radiopharma

He weighs in on key issues like solid tumors, allo, and in vivo CAR-T. Plus, alpha vs beta emitters in the radiopharma space. Coverage brought to you by

Bright Minds

1 day ago

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Evaluate is a trusted provider of forecasting and commercial intelligence to the pharmaceutical industry. With a combination of gold standard data sources and deep pharma expertise, Evaluate helps clients make the right portfolio decisions to drive growth.

Evaluate's solutions provide a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, underpinned by consensus forecasts to 2032, pipelines, deals and more. A consulting and analytics team is on always hand to help clients address unique clinical and commercial challenges.

Learn more about Evaluate

bottom of page

Miami Oncology Summit: Damian Green, Chief of Sylvester's Division of Transplantation and Cellular Therapy, discusses the latest in CAR-T and radiopharma

Follow BiotechTV

Sponsors

Sponsor Spotlight